ALBERT DAVID
|
The Current P/S Ratio of ALBERT DAVID is 1.40.
| Share Price | ₹773.5 | Dec 11,2025 |
| Market Cap | ₹440.9 Cr | |
| Sales-TTM | ₹315.8 Cr | TTM-Standalone Results |
| Price/Sales | 1.40x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ALBERT DAVID
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹440.9 Cr] as on Dec 11,2025
(/) Sales [ ₹315.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.40x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay '1.40 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ALBERT DAVID !
The chart below summarizes the trend in P/S Ratio of ALBERT DAVID over the last five years.
Historical PS (Price/Sales) ratio chart of ALBERT DAVID
PS Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.15x.
- ALBERT DAVID 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2024 at 1.69x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 0.86x.
How does ALBERT DAVID 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ALBERT DAVID | 315.8 | 1.40 | 440.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.89 | 433,536.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.03 | 170,753.0 |
| CIPLA LTD | 28,349.6 | 4.31 | 122,143.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.50 | 128,650.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.10 | 106,244.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.59 | 89,442.5 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.79 | 92,820.0 |
| LUPIN LTD | 24,750.7 | 3.84 | 95,030.1 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 68,099.0 |
| ABBOTT INDIA LTD | 6,714.4 | 8.93 | 59,982.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ALBERT DAVID 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.40x |
| Max industry PS | 17.03x |
| Median industry PS | 4.31x |
| Average industry PS | 6.32x |
You may also like the below Video Courses